Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Ferrer

Showing results (241-250 of 319) with videos related to

Pageof 32
Sort By:
JAMA|February 18, 2020
Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical TrialV Marco Ranieri, Ville Pettilä, Matti K Karvonen, et al.
Chest|March 7, 2021
Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective CohortJessica González, Iván D Benítez, Paola Carmona, et al.
The Lancet. Respiratory Medicine|June 3, 2023
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trialBruno François, Simon Lambden, Tom Fivez, et al.
BMJ Open|April 3, 2023
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injuryPeter Pickkers, Derek C Angus, Jacques Arend, et al.
Journal of Critical Care|February 26, 2022
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19Luis Felipe Reyes, Alejandro Rodriguez, Alirio Bastidas, et al.
The European Respiratory Journal|November 26, 2021
Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational studyAnna Motos, Alexandre López-Gavín, Jordi Riera, et al.
Ebiomedicine|April 4, 2021
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challengeMartin S Winkler, Tomasz Skirecki, Frank M Brunkhorst, et al.
Intensive Care Medicine|February 10, 2023
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort studyAlexis Tabah, Niccolò Buetti, Quentin Staiquly, et al.
European Journal of Clinical Investigation|January 29, 2021
Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasmaAna P Tedim, Raquel Almansa, Marta Domínguez-Gil, et al.
Frontiers in Medicine|February 21, 2022
Bronchial Aspirate-Based Profiling Identifies MicroRNA Signatures Associated With COVID-19 and Fatal Disease in Critically Ill PatientsMarta Molinero, Iván D Benítez, Jessica González, et al.
Pageof 32

Showing results (241-250 of 319) with videos related to

Sort By:
Pageof 32
JAMA|February 18, 2020
Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical TrialV Marco Ranieri, Ville Pettilä, Matti K Karvonen, et al.
Chest|March 7, 2021
Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective CohortJessica González, Iván D Benítez, Paola Carmona, et al.
The Lancet. Respiratory Medicine|June 3, 2023
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trialBruno François, Simon Lambden, Tom Fivez, et al.
BMJ Open|April 3, 2023
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injuryPeter Pickkers, Derek C Angus, Jacques Arend, et al.
Journal of Critical Care|February 26, 2022
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19Luis Felipe Reyes, Alejandro Rodriguez, Alirio Bastidas, et al.
The European Respiratory Journal|November 26, 2021
Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational studyAnna Motos, Alexandre López-Gavín, Jordi Riera, et al.
Ebiomedicine|April 4, 2021
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challengeMartin S Winkler, Tomasz Skirecki, Frank M Brunkhorst, et al.
Intensive Care Medicine|February 10, 2023
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort studyAlexis Tabah, Niccolò Buetti, Quentin Staiquly, et al.
European Journal of Clinical Investigation|January 29, 2021
Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasmaAna P Tedim, Raquel Almansa, Marta Domínguez-Gil, et al.
Frontiers in Medicine|February 21, 2022
Bronchial Aspirate-Based Profiling Identifies MicroRNA Signatures Associated With COVID-19 and Fatal Disease in Critically Ill PatientsMarta Molinero, Iván D Benítez, Jessica González, et al.
Pageof 32